Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
How to use and report data on D‐dimer testing in the COVID‐19 era?
Saved in:
| Published in: | Research and Practice in Thrombosis and Haemostasis |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2022
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: How to use and report data on D‐dimer testing in the COVID‐19 era?
- Uncertainties on the prognostic value of admission D‐dimer on venous thromboembolism occurrence in patients with COVID‐19
- Pulmonary embolism–related mortality during the COVID‐19 pandemic: Data from the United States
- From Data Stewardship to Model Stewardship: Extending Governance Frameworks for AI Era Health Data Use
- Positive fluid balance is associated with earlier acute kidney injury in COVID-19 patients
- Admission biomarkers and COVID-19 mortality: A retrospective study during Vietnam’s pandemic peak
- Correction: Hybrid Care Modifications in the Delivery of Nonpandemic Care During the COVID-19 Pandemic: Scoping Review